Value-Based Pricing: Panacea, Building Block, or Pipe Dream?

Wednesday, March 21, 2018

4:30 p.m.–6 p.m. (doors open at 4 p.m.)
Hiebert Lounge
72 East Concord Street


This presentation will discuss value assessment—including the use of cost-effectiveness and budgetary impact analyses in decision-making—and will contrast approaches taken in other high-income countries with those in the United States. Daniel Ollendorf will touch on what is included in the umbrella term “value-based pricing,” and will discuss under what circumstances various approaches to negotiation, such as outcomes-based contracting, amortized payments, and negotiated discounts, may or may not be value based.


Ollendorf, Dan photo smallDaniel Ollendorf, Chief Scientific Officer, Institute for Clinical and Economic Review